Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...
20h
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback